healthcare.digital November 16, 2024
Lloyd Price

Exec Summary:

Merative, formerly known as IBM Watson Health, is gearing up to introduce a range of new products in 2025. This comes after Francisco Partners, a private equity firm, acquired the health analytics assets of IBM Watson Health in 2022 and rebranded the division as Merative.

The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services.

Merative’s product portfolio will focus on six key areas:

  1. Health Insights: Providing actionable insights to improve healthcare delivery and decision-making.

  2. MarketScan: Offering comprehensive data on healthcare costs and utilisation trends.

  3. Clinical Development: Supporting...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Analytics, Technology
M&A: Health Catalyst Acquires Upfront Healthcare Services
Health Catalyst Buys Upfront, Announces Partnership With Databricks
What to expect in US healthcare in 2025 and beyond
Intermountain Sells Behavioral Health Analytics Model to NeuroFlow
MultiPlan refinances to extend debt capital structure

Share This Article